| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 25 Apr 2025 | 21 Apr 2025 |
| Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 inter alia to consider and approve Audited Standalone Financial Results for the quarter and financial year ended March 31 2025. Pursuant to Regulation 33 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we enclose herewith the following: 1. the Standalone Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025 together with the Report of Auditors on the said Results, duly approved and taken on record by the Board of Directors of the Company at their meeting held today, i.e., April 25, 2025; and 2. Declaration under Regulation 33(3)(d) of SEBI LODR Submission of Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025 (As per BSE Announcement Dated on 25/04/2025) | ||
| Board Meeting | 28 Jan 2025 | 18 Jan 2025 |
| ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 inter alia to consider and approve unaudited standalone financial results for the quarter and nine months ended December 31 2024. Unaudited Financial Results for the quarter and nine months ended December 31, 2024 (As Per BSE Announcement dated on 28.01.2025) | ||
| Board Meeting | 23 Oct 2024 | 17 Oct 2024 |
| ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the Unaudited Standalone Financial Results for the quarter and half year ended September 30 2024 Unaudited Financial Results for the quarter and half year ended September 30, 2024 and appointment of Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) of the Company with immediate effect. (As Per BSE Announcement dated on 23.10.2024) | ||
| Board Meeting | 26 Jul 2024 | 18 Jul 2024 |
| ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve Quarterly Standalone Financial Results for Q1 of FY 2024-25. As per letter attached (As per BSE Announcement Dated on 26/07/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
